Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Gross Margin
Tibet Rhodiola Pharmaceutical Holding Co
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 12.5B CNY |
| Gross Margin |
95%
|
| Country | US |
| Market Cap | 72.1B USD |
| Gross Margin |
4%
|
| Country | US |
| Market Cap | 44.4B USD |
| Gross Margin |
3%
|
| Country | US |
| Market Cap | 35.4B USD |
| Gross Margin |
3%
|
| Country | US |
| Market Cap | 23.9B USD |
| Gross Margin |
3%
|
| Country | US |
| Market Cap | 9.4B USD |
| Gross Margin |
31%
|
| Country | KR |
| Market Cap | 12.2T KRW |
| Gross Margin |
30%
|
| Country | CN |
| Market Cap | 69.4B HKD |
| Gross Margin |
8%
|
| Country | CN |
| Market Cap | 59.9B CNY |
| Gross Margin |
31%
|
| Country | IT |
| Market Cap | 7.6B EUR |
| Gross Margin |
65%
|
| Country | CN |
| Market Cap | 52B CNY |
| Gross Margin |
12%
|
Profitability Report
View the profitability report to see the full profitability analysis for Tibet Rhodiola Pharmaceutical Holding Co.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Tibet Rhodiola Pharmaceutical Holding Co's most recent financial statements, the company has Gross Margin of 94.9%.
You don't have any saved screeners yet
